Supplementary Figure 1 from Prevalence and Clinical Implications of Epstein–Barr Virus Infection in <i>De Novo</i> Diffuse Large B-Cell Lymphoma in Western CountriesChi Young Ok, Ken H. Young, Ling Li et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from Prevalence and Clinical Implications of Epstein–Barr Virus Infection in <i>De Novo</i> Diffuse Large B-Cell Lymphoma in Western CountriesChi Young Ok, Ken H. Young, Ling Li et al.|Unknown|2023Cited by 0
Supplementary Table 1 from Prevalence and Clinical Implications of Epstein–Barr Virus Infection in <i>De Novo</i> Diffuse Large B-Cell Lymphoma in Western CountriesChi Young Ok, Ken H. Young, Govind Bhagat et al.|Unknown|2023Cited by 0
Data from Prevalence and Clinical Implications of Epstein–Barr Virus Infection in <i>De Novo</i> Diffuse Large B-Cell Lymphoma in Western CountriesChi Young Ok, Ken H. Young, Ling Li et al.|Unknown|2023Cited by 0
Data from Prevalence and Clinical Implications of Epstein–Barr Virus Infection in <i>De Novo</i> Diffuse Large B-Cell Lymphoma in Western CountriesChi Young Ok, Ken H. Young, Ling Li et al.|Unknown|2023Cited by 0